Germany Moves to Secure Stake in Virus Vaccine Developer

(Bloomberg) -- Germany will buy a stake in CureVac AG, a player in the hotly contested race for a coronavirus vaccine, as governments jockey to ensure a supply of any successful pandemic shot.
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.